Prometheus Biosciences is a biotechnological company that researches and develops novel therapeutics to treat gastroenterology and bowel diseases.
Business Model:
Revenue: $7.2M
Employees: 51-200
Prometheus Biosciences was acquired by
Merck.
The acquisition happend on 2023-04-16.
Details of the transaction were not public
Address: 9410 Carroll Park Drive
City: San Diego
State: CA
Zip: 92121
Country: US
Prometheus Biosciences is a biotechnological company that researches and develops novel therapeutics to treat gastroenterology and bowel diseases.
Contact Phone:
+18588240895
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/11/2021
IPO Valuation:
$708M
Ticker Symbol:
RXDX
IPO Price:
$19/share
Amount Raised:
$190M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2010 | Debt Financing | $260M | 10/2017 | Series A | $3.7M | 3/2021 | IPO | $190M | 11/2020 | Equity | 10 | $130M |
Ascend Global Investments Cedars Sinai Cormorant Capital Cowen Healthcare Investments Eventide Irving Investors Nestlé Perceptive Advisors Point72 RTW Investments Cowen Healthcare Investments Nestlé Cedars Sinai Ascend Global Investments Cormorant Capital RTW Investments Eventide Point72 Irving Investors Perceptive Advisors Eventide RTW Investments |
12/2022 | Post-IPO Equity | $469.7M | 11/2018 | Venture Round | $10.1M | 6/2019 | Venture Round | $48.1M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|